Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F72VL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,892
Award facts
- Contract value 100% obligated
- $33,892.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on December 8, 2025, for Zepbound 10 mg/0.5 ml pen injectors valued at $33,892.10. This non-competitive delivery order is scheduled for completion by December 9, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle that extends through December 2026 and enables global medical supply delivery to military healthcare programs and other government medical systems.
AmerisourceBergen's receipt of this delivery order reflects its established position as a critical vendor within the DLA's Medical Supply Chain, where it supplies a broad range of pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare systems. Zepbound, a GLP-1 receptor agonist medication used for weight management, represents one of many specialty medications the company delivers through its federal contracts. The DLA's selection of AmerisourceBergen for this delivery order demonstrates the vendor's competitive capability to fulfill federal pharmaceutical procurement requirements at scale, consistent with its track record of managing diverse medical product deliveries through firm fixed-price arrangements ranging from nominal to substantial order values.
Quick answers
Who was awarded contract SPE2DR26F72VL?
SPE2DR26F72VL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F72VL worth?
The government has obligated $33,892 on SPE2DR26F72VL.
Is contract SPE2DR26F72VL an order under another contract?
Yes. SPE2DR26F72VL is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72VL competed?
The extent of competition for SPE2DR26F72VL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award